Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Weight & Measure cover art

Weight & Measure

Weight & Measure

Written by: Michael Donnelly-Boylen and Zach Niemiec
Listen for free

About this listen
Weight & Measure with Mike and Zach is an obesity podcast featuring conversations with patients, obesity medicine physicians, metabolic & bariatric surgery experts, researchers, dietitians, and advocates. We explore GLP-1 medications, obesity management medications (OMMs), weight loss medications, bariatric surgery, nutrition, body composition, obesity research, patient advocacy, insurance access, and long-term obesity treatment. Every episode combines lived experience with clinical expertise to support patients and healthcare professionals.Michael Donnelly-Boylen and Zach Niemiec Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Should I Skip My GLP-1 for the Holidays?
    Nov 16 2026

    Should I Skip My GLP-1 for the Holidays?

    The holidays are here, and for people taking GLP-1 medications like Wegovy, Zepbound, or Ozempic, that can bring up a question: Should I skip my GLP-1 so I can enjoy holiday meals?

    In this special crossover episode of Weight & Measure with Mike and Zach and Your GLP-1 Bestie, Mike is joined by registered dietitian, certified personal trainer, and author Gianna Beasley to talk about navigating the holiday season while taking obesity management medications (OMMs).

    From Thanksgiving dinner and family gatherings to changing appetites, food noise, and gastrointestinal side effects, Mike and Gianna explore what it means to enjoy the holidays when your relationship with food may look different than it once did.

    And perhaps most importantly, they challenge the idea that enjoying the holidays requires putting your health goals or treatment on hold.

    • Should you skip your GLP-1 for the holidays? Why some people consider delaying or skipping doses around holiday meals and the importance of discussing medication changes with your prescriber.

    • Managing GLP-1 side effects: Practical considerations for navigating nausea, fullness, and digestive discomfort when traditional holiday foods are on the menu.

    • Holiday eating without guilt: How to enjoy your favorite foods, honor your appetite, and move away from all-or-nothing thinking.

    • Food noise and changing traditions: How GLP-1 medications can reshape the way we experience food-centered celebrations.

    • Navigating family gatherings: Handling unwanted comments, food pressure, and conversations about your body or medication.

    • Building healthier holiday traditions: Finding joy in the season beyond what's on your plate.

    Mike and Gianna also share their personal experiences with holiday traditions, favorite foods, and the freedom that can come from changing your relationship with food.

    We're excited to announce our partnership with The Obesity Society for From Discovery to Impact: What Patients Measure, a special series connecting the latest obesity research with the experiences and priorities of people living with obesity.

    We'll bring conversations from ObesityWeek with researchers, clinicians, and patient advocates about emerging treatments, metabolic health, food noise, and what the science means for patients.

    Gianna Beasley, RDN, CPT

    • Podcast: Your GLP-1 Bestie

    • Instagram: @dietitian.gianna

    • Book: The GLP-1 Solution

    Obesity science doesn't have to be complicated, and nobody should have to navigate it alone.

    If you enjoyed this conversation, follow Weight & Measure on your favorite podcast platform, subscribe to our YouTube channel, and share this episode with someone navigating the holidays while taking a GLP-1 medication.

    Website: https://weightandmeasurepod.com

    YouTube: https://www.youtube.com/@WeightandMeasurePodcast

    Weight & Measure — Obesity science translated for the people living it.

    More science. Less stigma.

    Disclaimer: This podcast is intended for educational and informational purposes only and is not a substitute for individualized medical advice. Always consult your prescribing healthcare professional before changing your medication schedule.

    Show More Show Less
    47 mins
  • Do GLP-1s Cause Muscle Loss? Tirzepatide vs. Semaglutide | Research Round Up 11.13.2026
    Nov 13 2026

    Do GLP-1 medications cause muscle loss? And why can two people taking the same obesity medication have very different results?

    In the first Weight & Measure Research Roundup, Zach breaks down three new papers in under 14 minutes. We start with a study comparing tirzepatide and semaglutide: the difference in lean mass loss narrowed from 2.1 to 0.1 percentage points after researchers accounted for total weight lost. Zach explains what a body composition scan can tell us, why lean mass and skeletal muscle are different, and why strength and physical function belong in the conversation.

    We also look at whether rare genetic variants might help explain differences in semaglutide response, and what a map of 517 GLP-1 trials leaves unanswered about using Obesity Management Medications (OMMs) before or after metabolic & bariatric surgery.

    Chapters

    00:00 Welcome to the Research Roundup
    01:32 GLP-1 muscle loss headlines: What did the study measure?
    04:57 Could genetics influence semaglutide response?
    08:24 What 517 GLP-1 trials tell us about medication and surgery
    11:24 What should we measure beyond weight loss?

    Studies discussed

    • Tirzepatide vs. semaglutide and lean mass in routine care — npj Exercise Medicine and Health

    • Rare GLP1R variants and response to semaglutide or tirzepatide — Nature Metabolism

    • A systematic evidence map of 517 GLP-1 clinical trials — Obesity Surgery

    Would you like more short research episodes between our regular conversations? Tell us what question you’d like us to cover next. Follow Weight & Measure wherever you listen, subscribe on YouTube, and read the weekly Research Roundup.

    More science. Less stigma.

    Show More Show Less
    13 mins
  • FNCE 2026: GLP-1s, Protein Hype & What Dietitians Want You to Know
    Nov 9 2026

    GLP-1 medications are transforming nutrition care, protein is being added to everything, and nutrition misinformation continues to challenge patients and practitioners. So what did we learn at FNCE 2026?

    In this special episode of Weight & Measure with Mike and Zach, we're sharing our reactions and biggest takeaways from the Academy of Nutrition and Dietetics' Food & Nutrition Conference & Expo (FNCE) 2026 in San Antonio.

    We discuss the growing challenge of nutrition misinformation, the importance of compassionate childhood obesity care, and why metabolic dysfunction-associated steatotic liver disease (MASLD) deserves greater attention.

    We also explore health equity in GLP-1 and diabetes treatment, the food industry's obsession with protein, the growing conversation around fiber, and the challenges of maintaining adequate nutrition, muscle, and physical performance while taking obesity management medications.

    Along the way, we reflect on our experiences at the conference, the evolving role of registered dietitians, and how our own experiences with nutrition counseling shape the way we view obesity care today.

    Our biggest takeaway? Better obesity care requires more than medications or weight loss. It requires evidence-based nutrition guidance, individualized support, and healthcare professionals who understand the people they're treating.

    Join us for a candid conversation about what caught our attention, what surprised us, and what we hope patients and practitioners take away from FNCE 2026.

    More Science. Less Stigma.

    Explore more and subscribe: https://weightandmeasurepod.com

    Show More Show Less
    33 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet